Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982;13(Suppl 2):317S–320S. doi: 10.1111/j.1365-2125.1982.tb01935.x

β-adrenoceptor blocking drugs

The relevance of intrinsic sympathomimetic activity

W J Louis, J J McNeil
PMCID: PMC1402176  PMID: 6125183

Abstract

1 This paper reviews the nature and clinical value of intrinsic sympathomimetic activity (ISA) as a property of β-adrenoceptor blocking drugs.

2 It suggests that ISA may reduce the incidence of certain cardiac, respiratory and peripheral vascular side effects including bronchospasm, peripheral vasospasm and rebound tachycardia and cardiac arrhythmias.

Full text

PDF
317S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barlow J. J., Main B. D., Moors J. A., Nuttall A., Snow H. M. The cardiovascular acitivity of ICI 118,587 a novel beta-adrenoceptor partial agonist [proceedings]. Br J Pharmacol. 1979 Nov;67(3):412P–412P. [PMC free article] [PubMed] [Google Scholar]
  2. Formgren H., Eriksson N. E. Effects of practolol in combination with terbutaline in the treatment of hypertension and arrhythmias in asthmatic patients. Scand J Respir Dis. 1975;56(4):217–222. [PubMed] [Google Scholar]
  3. Frishman W., Davis R., Strom J., Elkayam U., Stampfer M., Ribner H., Weinstein J., Sonnenblick E. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 5. Pindolol (LB-46) therapy for supraventricular arrhythmia: a viable alternative to propranolol in patients with bronchospasm. Am Heart J. 1979 Sep;98(3):393–398. doi: 10.1016/0002-8703(79)90053-x. [DOI] [PubMed] [Google Scholar]
  4. Frishman W., Silverman R., Strom J., Elkayam U., Sonnenblick E. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker. Am Heart J. 1979 Aug;98(2):256–262. doi: 10.1016/0002-8703(79)90229-1. [DOI] [PubMed] [Google Scholar]
  5. Frohlich E. D., Tarazi R. C., Dustan H. P. Peripheral arterial insufficiency. A complication of beta-adrenergic blocking therapy. JAMA. 1969 Jun 30;208(13):2471–2472. doi: 10.1001/jama.208.13.2471. [DOI] [PubMed] [Google Scholar]
  6. GLOVER W. E., GREENFIELD A. D., SHANKS R. G. Effect of dichloroisoprenaline on the peripheral vascular responses to adrenaline in man. Br J Pharmacol Chemother. 1962 Oct;19:235–244. doi: 10.1111/j.1476-5381.1962.tb01185.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hugues F. C., Julien D., Bors V., Marche J. Effets de différents bêta-bloqueurs sur le débit expiratoire de l'asthmatique. Therapie. 1976 Sep-Oct;31(5):595–603. [PubMed] [Google Scholar]
  8. Johnsson G., Svedmyr N., Thiringer G. Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics. Eur J Clin Pharmacol. 1975 Apr 4;8(3-4):175–180. doi: 10.1007/BF00567111. [DOI] [PubMed] [Google Scholar]
  9. MCNEILL R. S. EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS. Lancet. 1964 Nov 21;2(7369):1101–1102. doi: 10.1016/s0140-6736(64)92617-0. [DOI] [PubMed] [Google Scholar]
  10. Marshall A. J., Roberts C. J., Barritt D. W. Raynaud's phenomenon as side effect of beta-blockers in hypertension. Br Med J. 1976 Jun 19;1(6024):1498–1499. doi: 10.1136/bmj.1.6024.1498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McNeil J. J., Louis W. J. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension. Br J Clin Pharmacol. 1979;8(Suppl 2):163S–166S. [PMC free article] [PubMed] [Google Scholar]
  12. Miller R. R., Olson H. G., Amsterdam E. A., Mason D. T. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med. 1975 Aug 28;293(9):416–418. doi: 10.1056/NEJM197508282930902. [DOI] [PubMed] [Google Scholar]
  13. Minneman K. P., Hegstrand L. R., Molinoff P. B. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro. Mol Pharmacol. 1979 Jul;16(1):21–33. [PubMed] [Google Scholar]
  14. Oh V. M., Kaye C. M., Warrington S. J., Taylor E. A., Wadsworth J. Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise. Br J Clin Pharmacol. 1978 Feb;5(2):107–120. doi: 10.1111/j.1365-2125.1978.tb01609.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ross P. J., Lewis M. J., Sheridan D. J., Henderson A. H. Adrenergic hypersensitivity after beta-blocker withdrawal. Br Heart J. 1981 Jun;45(6):637–642. doi: 10.1136/hrt.45.6.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rönn O., Fellenius E., Graffner C., Johnsson G., Lundborg P., Svensson L. Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in man. Eur J Clin Pharmacol. 1980 Feb;17(2):81–86. doi: 10.1007/BF00562614. [DOI] [PubMed] [Google Scholar]
  17. SAYERS G., SOLOMON N. Work performance of a rat heart-lung preparation: standardization and influence of corticosteroids. Endocrinology. 1960 May;66:719–730. doi: 10.1210/endo-66-5-719. [DOI] [PubMed] [Google Scholar]
  18. Svendsen T. L., Hartling O., Trap-Jensen J. Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers. Eur J Clin Pharmacol. 1979 May 21;15(4):223–228. doi: 10.1007/BF00618509. [DOI] [PubMed] [Google Scholar]
  19. Tuttle R. R., Mills J. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res. 1975 Jan;36(1):185–196. doi: 10.1161/01.res.36.1.185. [DOI] [PubMed] [Google Scholar]
  20. Wale J. L., Austin M., Conway J., Reeves M. The influence of the intrinsic sympathomimetic activity of beta-adrenoceptor antagonists on haemodynamic effects in anaesthetized dogs. Clin Exp Pharmacol Physiol. 1979 Jan-Feb;6(1):11–19. doi: 10.1111/j.1440-1681.1979.tb00002.x. [DOI] [PubMed] [Google Scholar]
  21. Zacharias F. J., Cowen K. J., Prestt J., Vickers J., Wall B. G. Propranolol in hypertension: a study of long-term therapy, 1964-1970. Am Heart J. 1972 Jun;83(6):755–761. doi: 10.1016/0002-8703(72)90206-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES